Study of AP endonuclease (APEX1/REF1), a DNA repair enzyme, in gallbladder carcinoma.
Abstract
AIM
This study investigated the levels of Apurinic/Apyrimidinic Endonuclease (APEX1) in gallbladder carcinoma (CaGB) tissue and
co-related these levels with various clinicopathological parameters.
PATIENTS AND METHODS
Twenty cases of CaGB and cholelithiasis were included in the study. Western blot analysis of APEX1 protein was performed using
actin as the reference point. Densitometric analysis and the integrated density value (IDV) of APEX1 protein samples were
determined. The ratio of IDV of APEX1/actin was determined.
RESULTS
The mean IDV ratio of APEX1 in CaGB was 0.63±0.33 and 0.45±0.19 in cholelithiasis. The mean IDV ratio of a variant of APEX1
(ΔAPEX1) in CaGB was 0.50±0.09, whereas it was 0.40±0.16 in cholelithiasis. Calculating the mean IDV ratio of total APEX (APEX1+ΔAPEX1)
in CaGB was 1.13±0.31 whereas in cholelithiasis, 0.85±0.23. The differences were statistically significant (p<0.05).
CONCLUSION
A significant correlation was found between the relative expressions of APEX1 in cancer as compared to that in cholelithiasis
patients. There was significant association between APEX1 expression and perineural invasion. A variant of APEX1 correlated
with tumor infiltration. Hence APEX1 may be of use as a prognostic marker in patients with CaGB.
Links
Authors
Shukla VK, das PC, Dixit R, Bhartiya SK, Basu S, Raman MJ
Institution
Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. vkshuklabhu@gmail.com
Source
Anticancer research 32:4 2012 Apr pg 1489-92MeSH
AdultAged
DNA Repair
DNA-(Apurinic or Apyrimidinic Site) Lyase
Female
Gallbladder Neoplasms
Humans
Male
Middle Aged
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22493391
Log In

